
Wanbury Ltd Valuation Shifts to Fair Amid Strong Fundamentals and Market Outperformance
2026-05-21 08:01:23Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change comes amid a backdrop of strong operational metrics and a mixed valuation landscape within its peer group, prompting investors to reassess the stock’s price attractiveness relative to historical and sector benchmarks.
Read More
Wanbury Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-05-20 11:00:14At Rs 271, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Wanbury Ltd locked at its upper circuit of 5% on 20 May 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Wanbury Ltd Technical Momentum Shifts Signal Bullish Outlook Amid Micro-Cap Surge
2026-05-20 08:04:26Wanbury Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, upgrading its outlook from mildly bullish to bullish. This change is underscored by a combination of positive signals from key technical indicators including MACD, Bollinger Bands, and moving averages, suggesting renewed investor interest and potential upside in the near term.
Read More
Wanbury Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-05-13 12:00:06At Rs 261.55, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Wanbury Ltd locked at its upper circuit of 5.0% on 12 May 2026, with buyers queuing and no sellers willing to part with shares.
Read MoreBoard Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
03-Aug-2026 | Source : BSEWanbury Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 that the meeting of the Board of Directors of Wanbury Limited is scheduled to be held on Tuesday August 11 2026 inter-alia to consider and approve the Un-audited Financial Results for the first quarter and three months ended June 30 2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
30-Jul-2026 | Source : BSEPress Release - No DMF deficiency letter received from the office of USFDA for multiple ANDAs
Intimation Of Completion Of Inspection By The United States Food And Drug Administration (USFDA) At The Companys Facility At Tanuku West Godavari District Andhra Pradesh
22-Jul-2026 | Source : BSEIntimation of completion of inspection by the United States Food and Drug Administration (USFDA) at the Companys Facilty.
Corporate Actions
(11 Aug 2026)
Wanbury Ltd has declared 10% dividend, ex-date: 29 Jul 10
No Splits history available
No Bonus history available
No Rights history available